Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin.
Dermatol Reports
; 14(4): 9490, 2022 Nov 21.
Article
en En
| MEDLINE
| ID: mdl-36545271
ABSTRACT
Periungual warts are commonly resistant to treatment, especially in immunocompromised patients. Many treatment modalities have been used with variable results. Bleomycin is one of the most effective treatments for recalcitrant warts, including the periungual type. It can be used either as a topical application after needling or as a direct injection. We report complete clearance of multiple periungual warts in an immunocompromised patient after diluted bleomycin injection. The patient did not have a recurrence after eight months of follow up.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Dermatol Reports
Año:
2022
Tipo del documento:
Article
País de afiliación:
Arabia Saudita